Atlas Trials

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Clinical trial NCT02338414 · UNKNOWN

Trial details

NCT number
NCT02338414
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2015-01-01
Primary completion
2015-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.